The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases

The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases

High-density lipoprotein (HDL) is a set of particles with heterogeneous structures that have different functions due to various compounds including surface charge, size, lipid, and protein compounds. Several prospective epidemiological studies have demonstrated that there is a clear inverse relation...

Full description

Bibliographic Details
Main Authors:	Malihe Aghasizadeh, Majid Ghayour Mobarhan, Toba Kazemi, Amir Avan, Ebrahim Miri Moghaddam
Format:	Article
Language:	fas
Published:	Birjand University of Medical Sciences and Health Services 2020-06-01
Series:	Journal of Birjand University of Medical Sciences
Subjects:	atherosclerosis cardiovascular disease high density lipoprotein lipoprotein
Online Access:	http://journal.bums.ac.ir/article-1-2823-en.html

Similar Items

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020-04-01)

Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
by: Siri A. N. Holme, et al.
Published: (2020-08-01)

The role of high density lipoprotein compositional and functional heterogeneity in metabolic disease
by: Gordon, Scott M.
Published: (2012)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE
by: Stephen J. Nicholls, et al.
Published: (2020-10-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases
by: Ya D Babintseva, et al.
Published: (2016-09-01)

Lipoprotein Glomerulopathy-Like Lesions in Atherosclerotic Mice Defected With HDL Receptor SR-B1
by: Jiawei Liao, et al.
Published: (2021-10-01)

The role of neutrophil/high density lipoprotein, monocyte/high density lipoprotein and low density lipoprotein/high density lipoprotein ratios in determining the presence and severity of asymptomatic carotid stenosis in elderly persons
by: Aslı Bolayır, et al.
Published: (2021-04-01)

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
by: Kelley M. Argraves, et al.
Published: (2007-11-01)

Intestinal nuclear receptors in HDL cholesterol metabolism
by: Chiara Degirolamo, et al.
Published: (2015-07-01)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
by: Katya B. Rubinow, et al.
Published: (2012-07-01)

Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk
by: Laura Calabresi, et al.
Published: (2011-08-01)

Carbohydrate composition of circulating multiple-modified low-density lipoprotein
by: Zakiev ER, et al.
Published: (2016-10-01)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
by: Jacek Rysz, et al.
Published: (2020-01-01)

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins
by: Matthias Schneider, et al.
Published: (2005-04-01)

High-density lipoproteincholesterol, reverse cholesterol transport, and cardiovascular risk: a tale of genetics?
by: Giovanni Cimmino, et al.
Published: (2013-10-01)

Visualizing caveolin-1 and HDL in cholesterol-loaded aortic endothelial cells
by: W.T. Chao, et al.
Published: (2003-06-01)

Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01)

Plasma levels of lipoprotein-associated phospholipase A2 are increased in patients with β-thalassemia
by: Alexandros D. Tselepis, et al.
Published: (2010-11-01)

Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
by: Maria Camila Pruper de Freitas, et al.
Published: (2018-10-01)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
by: Maria Pia Adorni, et al.
Published: (2021-03-01)

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01)

Native High Density Lipoproteins (HDL) Interfere with Platelet Activation Induced by Oxidized Low Density Lipoproteins (OxLDL)
by: Ivo Volf, et al.
Published: (2013-05-01)

Role of lipoprotein (a) in the development of ischemic stroke and other cardiovascular diseases
by: N. A. Pizov, et al.
Published: (2016-03-01)

Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
by: Christian Schäfer, et al.
Published: (2007-07-01)

Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency
by: Agnieska Ćwiklińska, et al.
Published: (2018-06-01)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
by: Toth PP
Published: (2016-05-01)

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
by: Marie-Claude Blatter Garin, et al.
Published: (2006-03-01)

Could androgens or zinc underlie the role of HDL-cholesterol in cardiovascular disease : a review
by: Ng, Waai-yan, Tiffany, et al.
Published: (2014)

Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis
by: Michael S. Yee, et al.
Published: (2008-06-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

Lipoprotein(a) in the Evaluation of Cardiovascular Risk in the Portuguese Population
by: Joaquim A. Meireles-Brandão, et al.
Published: (2019-03-01)

Measurment of rhesus monkey (Macaca mulatta) apolipoprotein B in serum by radioimmunoassay: comparison of immunoreactivities of rhesus and human low density lipoproteins
by: J B Karlin, et al.
Published: (1978-02-01)

Atomistic MD simulation reveals the mechanism by which CETP penetrates into HDL enabling lipid transfer from HDL to CETP
by: Geraldine Cilpa-Karhu, et al.
Published: (2015-01-01)

Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL[S]
by: Naoko Sawada, et al.
Published: (2020-06-01)

Excessive centrifugal fields damage high density lipoprotein [S]
by: William H. Munroe, et al.
Published: (2015-06-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice
by: Rongsong Li, et al.
Published: (2013-06-01)